Biotech giant Monsanto announced a smaller net loss for the first
quarter of 2005 than the same period last year thanks mainly to
increasing seed sales, but legal problems are still proving
expensive for the company.
Martek Biosciences last week announced its year-end results, noting
increased revenues and "robust growth" due primarily to higher
sales of nutritional products to the company's infant formula
Cyanotech, the Hawaiian based nutraceutical firm, which saw a
return to profitability in fiscal 2004, appears to be benefiting
from growing public awareness of the health benefits of its
products, reporting solid results for the second...